Shaping Success: TFS Tackles RWE for a Line Extension in Newborn Respiratory Rarity
Download our case study to:
Discover how TFS harnessed the power of Real-World Evidence (RWE) to transform a high-stakes clinical trial into a groundbreaking respiratory treatment in newborns.
Discover the strategic pivot from a traditional RCT to a cost-effective RWE approach that navigated low enrollment, ethical hurdles, and regulatory challenges. Learn how our experts’ innovative solutions led to a successful study redesign, approved by the EMA, which is set to reshape newborn care. Download now to see how TFS is pioneering the future of pharmaceutical development with agility and insight.
Learn more about our related services and resources:
Connect with Us
Contact us today to discover how TFS can be your strategic CRO partner in clinical development.
Learn More About Our Real World Evidence Expertise
Top 10 Contract Research Organizations (CROs) for 2025
Top 10 Contract Research Organizations (CROs) for 2025
Harnessing Real-World Evidence (RWE) for Effective External Control Arms in Clinical Trials
Harnessing Real-World Evidence (RWE) for Effective External Control Arms in Clinical Trials
Leveraging Real-World Evidence (RWE) in Early-Phase Oncology Research